Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

BBLG vs CNEY: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CNEY Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 2–5 Matrix Metrics)

CNEY Overall Winner 6-Pillar Tally: BBLG 2 – 3 CNEY (1 Tie) Matrix Metrics: BBLG 5 – 2 CNEY

As of Nov 17, 2026, CN Energy Group Inc. Class A (CNEY) is the stronger overall head-to-head candidate over Bone Biologics Corp (BBLG) in the Tradestie Institutional Equity Comparison Engine, winning 2–5 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). BBLG carries a Unified Composite Score of 45.5/100 (HOLD) at $0.31 (N/M Forward P/E, 0.0% operating margin), whereas CNEY carries 35.1/100 (SELL) at $0.43 (N/M Forward P/E, -138.5% operating margin).

  • Composite vs. Pillar Nuance: While BBLG currently prints a higher short-term Unified Composite Score (45.5/100 HOLD vs. CNEY 35.1/100 SELL), CNEY captures the overall institutional head-to-head verdict (2–5 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (-138.5% vs. 0.0% operating margin) and revenue trajectory (+8.2% vs. +0.0% YoY).
  • Technical & Structure Timing Caution: BBLG is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 31.5); meanwhile CNEY is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BBLG vs CNEY
BBLG NASDAQ
Bone Biologics Corp Common Stock
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.31
+5.13% 1D
Market Cap $1.1M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.99β · 100% Vol
Unified Composite Score
45.5 / 100 HOLD
Tech 33.0 Fund 54.0 Flow 50.0 Mom 84.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -19.7%), weak momentum, RSI 31
RSI-14: 31.5 · SMA20: $0.36 · SMA50: $0.43
CNEY NASDAQ Head-to-Head Winner
CN Energy Group Inc. Class A Ordinary Shares
Industrial Organic Chemicals
$0.43
-9.9% 1D
Market Cap $2.6M
TTM Revenue $37M
Forward P/E N/M
Beta / 30D Vol 0.67β · 104% Vol
Unified Composite Score
35.1 / 100 SELL
Tech 15.0 Fund 45.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -8.5%), weak momentum, RSI 40
RSI-14: 40.4 · SMA20: $0.48 · SMA50: $0.50

6-Pillar Scorecard Institutional Category Breakdown (BBLG 2 – 3 CNEY)

Columns: Metric · BBLG · CNEY
1. Valuation Multiples CNEY
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M 0.1x
2. Growth & Scale CNEY
Revenue Growth (YoY) +0.0% +8.2%
Earnings Growth (YoY) +0.0% +76.7%
TTM Revenue (USD) N/A $37M
Market Cap $1.1M $2.6M
3. Profitability & Quality BBLG
Gross Margin N/A 1.1%
Operating Margin 0.0% -138.5%
Net Profit Margin 0.0% -183.1%
Return on Equity (ROE) -47.5% -84.3%
4. Balance Sheet & Cash Flow BBLG
Cash Generation (TTM) -$2.6M -$50M EBITDA
Cash Flow Margin N/A -136.7% EBITDA Mgn
Net Cash / Leverage $1.76 Book/Sh · -47.5% ROE $4.74 Book/Sh · -84.3% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning CNEY
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase ACCUMULATION · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Specialty Chemicals Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BBLG (5) vs CNEY (2)
Institutional Metric BBLG CNEY Criterion Row Edge
Market Capitalization
Scale
$1.1M $2.6M Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+0.0% +8.2% Higher Growth CNEY
Operating Margin (TTM)
Profitability
0.0% -138.5% Higher Margin BBLG
Net Profit Margin
Profitability
0.0% -183.1% Higher Margin BBLG
Return on Equity (ROE)
Capital Efficiency
-47.5% -84.3% Higher ROE BBLG
52-Week Range Position
Momentum
2% ($0–$2) 5% ($0–$3) Stronger Trend CNEY
Beta / 30D Volatility
Risk Regime
0.99β · 100% Vol 0.67β · 104% Vol Lower Realized Risk BBLG
Unified Institutional Score
Composite Signal
45.5 / 100 (HOLD) 35.1 / 100 (SELL) Higher Composite BBLG
Trailing 12M Revenue (USD)
Operating Scale
N/A $37M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 1.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 0.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$2.6M ($1.76 Book/Sh · -47.5% ROE) -$50M EBITDA ($4.74 Book/Sh · -84.3% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CNEY +33.81 pp
BBLG: -24.65% · CNEY: +9.16%
3M Horizon CNEY +23.28 pp
BBLG: -51.69% · CNEY: -28.41%
6M Horizon CNEY +2.31 pp
BBLG: -75.45% · CNEY: -73.14%
1Y Horizon CNEY +7.53 pp
BBLG: -80.67% · CNEY: -73.14%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BBLG vs CNEY. Trailing 12-month operating profitability (BBLG 0.0% vs CNEY -138.5%) and valuation multiples (BBLG N/M vs CNEY N/M Forward P/E) are benchmarked directly in Pillar 4 below.

BBLG ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E-47.5% · N/M
CNEY ADR TTM Benchmark FX-Normalized USD
TTM Revenue$37M
Gross Margin1.1%
Op. Margin-138.5%
ROE / Fwd P/E-84.3% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BBLG BREAKDOWN
104d in phase · OBV ACCUMULATION
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow ACCUMULATION
Exact BBLG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CNEY UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CNEY Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BBLG Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $1.1M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
CNEY Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $2.6M market capitalization and -138.5% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ BBLG vs CNEY Key Questions & Quantitative Answers

As of Nov 17, 2026, CN Energy Group Inc. Class A (CNEY) is the stronger overall head-to-head candidate over Bone Biologics Corp (BBLG) in the Tradestie Institutional Equity Comparison Engine, winning 2–5 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). BBLG carries a Unified Composite Score of 45.5/100 (HOLD) at $0.31 (N/M Forward P/E, 0.0% operating margin), whereas CNEY carries 35.1/100 (SELL) at $0.43 (N/M Forward P/E, -138.5% operating margin). Composite vs. Pillar Nuance: While BBLG currently prints a higher short-term Unified Composite Score (45.5/100 HOLD vs. CNEY 35.1/100 SELL), CNEY captures the overall institutional head-to-head verdict (2–5 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (-138.5% vs. 0.0% operating margin) and revenue trajectory (+8.2% vs. +0.0% YoY). Technical & Structure Timing Caution: BBLG is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 31.5); meanwhile CNEY is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CNEY leads the Growth & Scale pillar: BBLG posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with CNEY at +8.2% YoY revenue growth and +76.7% YoY earnings growth on $37M TTM revenue (1.1% gross margin, -138.5% operating margin). On trailing 12-month operating scale, BBLG generates N/A in USD-normalized revenue versus $37M for CNEY. In operating R&D and SG&A reinvestment, BBLG deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CNEY.

CNEY screens cheaper on headline valuation multiples. BBLG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin), whereas CNEY trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-136.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BBLG (-47.5% ROE) versus CNEY (-84.3% ROE) capital efficiency.

In options market volatility and institutional positioning, BBLG carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (0.99β · 100% Vol realized risk). By comparison, CNEY carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.67β · 104% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.